Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Small Cell Lung Carcinoma 3Neoplasms 1Extensive Stage Small Cell Lung Cancer (ES-SCLC) 1

Interventions

Carboplatin 47Etoposide 46durvalumab 28atezolizumab 28Cisplatin 21Topotecan 19pembrolizumab 15PM 01183 15Nivolumab 12Specimen Handling 11anlotinib 9Radiotherapy 9Paclitaxel 9Drug Therapy 9Temozolomide 8Magnetic Resonance Spectroscopy 8AMG 757 8Radiosurgery 7Platinum 7Irinotecan 7toripalimab 6olaparib 6Biopsy 6Ipilimumab 5Injections 5Docetaxel 5Bevacizumab 5trilaciclib 4tremelimumab 4tislelizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Small Cell Lung Carcinoma × amrubicin × 1 year × Clear all
NCT06203210 2026-06-02

IDeate-Lung02

Daiichi Sankyo

Phase 3 Recruiting
540 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT07365241 2026-01-26

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

AbbVie

Phase 3 Not yet recruiting
531 enrolled
Thoracic

Neoplasms, Small Cell Lung Carcinoma

NCT05740566 2026-01-05

DeLLphi-304

Amgen

Phase 3 Active not recruiting
509 enrolled 11 charts 1 FDA
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡